Abstract
It is well known that silent myocardial ischemia (SMI) often complicates patients with cerebral infarction and that stroke patients often die of ischemic heart disease. Therefore, it is considered important to treat myocardial ischemia in stroke patients. This study investigated SMI complicating Japanese patients with fresh stroke, using 99mTc-tetrofosmin myocardial scintigraphy with pharmacologic stress testing to elucidate their clinical manifestations. This study included 41 patients (26 men, mean age 76.0 ± 10.7 years) with acute cerebral infarction and no history of coronary artery disease. All patients underwent 99mTc-tetrofosmin myocardial scintigraphy with intravenous administration of adenosine to diagnose SMI. Of the 41 patients, myocardial ischemia was confirmed in 17 patients (41.5%). Atherosclerotic etiology was the major cause of stroke in the ischemia(+) group and embolic origin was the major cause in the ischemia(−) group. Patients with myocardial ischemia had a higher incidence of diabetes mellitus (52.9 vs 20.8%; P = 0.0323) and more than two conventional cardiovascular risk factors (64.7 vs 25.0%; P = 0.0110) compared with the nonischemic patients. Infarction subtype of atherosclerotic origin was an independent positive predictor of asymptomatic myocardial ischemia in patients with stroke. These findings indicate that the prevalence of asymptomatic myocardial ischemia is relatively high, especially in patients with stroke of atherosclerotic origin. Therefore, it is beneficial for us to narrow the target population who are at the highest risk when screening for SMI in Japanese patients with acute cerebral infarction.
Similar content being viewed by others
References
Adams RJ, Chimowitz MI, Alpert JS, Awad IA, Cerqueria MD, Fayad P, Taubert KA (2003) Coronary risk evaluations in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the stroke council and the council on clinical cardiology of the American Heart Association/American Stroke Association. Circulation 108:1278–1290
Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas J (2005) Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 36:2748–2755
Amarenco P, Lavallée PC, Labreuche J, Ducrocq G, Juliard JM, Feldman L, Mesequer E, Guidoux C, Adraï V, Ratani S, Kusmierek J, Lapergue B, Klein IF, Gongora-Rivera F, Jaramillo A, Mazighi M, Touboul PJ, Steg PG (2011) Prevalence of coronary atherosclerosis in patients with cerebral infarction. Stroke 42:22–29
Arauz A, Calleja J, Vallejo E, Quintero L (2010) Prevalence of silent myocardial ischemia in single and multiple lacunar infarcts and large vessel disease stroke. Clin Neurol Neurosurg 112:658–661
Arenillas JF, Candell-Riera J, Romero-Farina G, Molina CA, Chacon P, Aguade-Bruix S, Montaner J, de Leon G, Castell-Conesa J, Alvarez-Sabin J (2005) Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: associated factors. Stroke 36:1201–1206
Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, Pessin MS, Bleich HL (1978) The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 28:754–762
Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, Wolf PA (1989) Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 25:382–390
Cerqueria MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American Heart Association. Circulation 105:539–542
Berman DS, Abidov A, Kang X, Hayes SW, Friedman JD, Sciammarella MG, Cohen I, Gerlach J, Waechter PB, Germano G, Hachamovitch R (2004) Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol 11:414–423
Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S (2008) Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging 35:319–328
Hoshino A, Nakamura T, Enomoto S, Kawahito H, Kurata H, Nakahara Y, Ijichi T (2008) Prevalence of coronary artery disease in Japanese patients with cerebral infarction—impact of metabolic syndrome and intracranial large artery atherosclerosis. Circ J 72:404–408
Dorbala S, Hachamovitch R, Di Carli MF (2006) Myocardial perfusion imaging and multidetector computed tomographic coronary angiography: appropriate for all patients with suspected coronary artery disease? J Am Coll Cardiol 48:2515–2517
Leber AW, Knez A, von Ziegler F, Becker A, Nikolaou K, Paul S, Wintersperger B, Reiser M, Becker CR, Steinbeck G, Boekstegers P (2005) Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol 46:147–154
Bermann DS (2006) Fourth annual Mario S. Verani, MD memorial lecture: noninvasive imaging in coronary artery disease: changing roles, changing players. J Nucl Cardiol 13:457–473
Kamal AM, Fattah AA, Pancholy S, Aksut S, Cave V, Heo J, Iskandrian AS (1994) Prognostic value of adenosine single-photon emission computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease. J Nucl Cardiol 1:254–261
Cuocolo A, Nicolai E, Soricelli A, Pace L, Nappi A, Sullo P, Cardei S, Argenziano L (1996) Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing. J Nucl Cardiol 3:194–203
Cohn PF, Fox KM, Daly C (2003) Silent myocardial ischemia. Circulation 108:1263–1277
Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579
Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Röther J, Wilson PW (2006) REACH Registry Investigators International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295:180–189
Steg PG, Bhatt DL, Wilson PW, D’Agostino R Sr, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S (2007) REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297:1197–1206
Abdelmoneim SS, Bernier M, Dhoble A, Moir S, Hagen ME, Ness SA, Pellikka PA, Abdel-Kader SS, Mulvagh SL (2010) Diagnostic accuracy of contrast echocardiography during adenosine stress for detection of abnormal myocardial perfusion: a prospective comparison with technetium-99m sestamibi single-photon emission computed tomography. Heart Vessels 25:121–130
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nomura, T., Kusaba, T., Kodama, N. et al. Clinical characteristics of silent myocardial ischemia diagnosed with adenosine stress 99mTc-tetrofosmin myocardial scintigraphy in Japanese patients with acute cerebral infarction. Heart Vessels 28, 27–33 (2013). https://doi.org/10.1007/s00380-011-0210-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-011-0210-9